Group 1 - As of April 28, 215 A-share companies have been newly held by social security funds in Q1 2023, with some companies having over 10% of their circulating shares held by these funds [1][2][3] - Notable companies include Andar Intelligent, which has 265.16 million shares held by the National Social Security Fund 103 portfolio, accounting for 12.15% of its circulating shares [1][3] - Industries such as metal smelting, chemical products, and communications are currently favored by social security fund portfolios, with companies like Baosteel, Cangge Mining, and Yiwei Lithium Energy being newly held [1][2][3] Group 2 - The National Social Security Fund 114 portfolio holds 158 million shares of Baosteel, with a market value of 1.14 billion yuan, making it the largest holding among newly acquired A-shares [2][8] - Cangge Mining and Yiwei Lithium Energy also show significant performance, with net profits of 447 million yuan (up 41.19%) and 1.1 billion yuan (up 3.32%) respectively in Q1 [2][8] - Other companies with strong Q1 performance include Baosteel, Cangge Mining, and Yiwei Lithium Energy, which are currently favored by social security funds [2][3] Group 3 - The QFII (Qualified Foreign Institutional Investor) also shows a diverse portfolio, with significant holdings in companies like Zijin Mining and Tonghuashun, indicating a broader industry focus compared to social security funds [9][10] - QFII has increased its holdings in various sectors, including finance and pharmaceuticals, while social security funds focus more on blue-chip and cyclical stocks [9][10] - The performance of different sectors in Q2 shows that public utilities, beauty care, agriculture, banking, and retail have seen increases, while basic chemicals, pharmaceuticals, and steel have declined [10]

Investment Rating - The report maintains an "Accumulate" rating for the company with a target price of 29.54 RMB [5][6]. Core Views - The company reported a steady performance in Q1 2025, achieving revenue of 1.5 billion RMB, with a quarter-on-quarter increase of 9% and a year-on-year increase of 4%. The net profit attributable to shareholders was 100 million RMB, showing a slight quarter-on-quarter increase of 0.7% but a year-on-year decrease of 4% [1]. - The company is expected to have growth potential due to the gradual ramp-up of new projects and the ongoing industrialization of electronic-grade PI and life sciences sectors [1]. - The company is expanding its market presence, particularly in the lubricant additive sector, with a focus on internationalization through the establishment of a research and production base in Malaysia [2]. - The life sciences segment has shown significant progress, with a pilot workshop for nucleic acid monomers and partnerships with nearly 90 clients, indicating a strong market transition from R&D to dual-track operations [3]. Summary by Sections Financial Performance - The company achieved a gross margin of 21.52% in Q1 2025, remaining stable compared to previous periods. The comprehensive expense ratio was 12%, with a slight increase attributed to higher R&D expenses [2]. - The forecast for net profit attributable to shareholders for 2025-2027 is 480 million, 530 million, and 580 million RMB, respectively, with year-on-year growth rates of 14%, 10%, and 10% [4]. Market Expansion - The company is actively exploring new markets, with a notable 15% increase in lubricant additive exports from Liaoning province in Q1 2025 [2]. - The establishment of a production base in Malaysia is expected to enhance the company's international competitiveness and risk resilience [2]. Business Development - The life sciences segment has made strides with the introduction of the phosphoramidite monomer into the supply chain of downstream clients, and the dNTP products have reached advanced domestic levels with over 70 client collaborations [3]. - The company has completed the acquisition of Yixing Chuangju and is set to supply flexible display leaders in bulk by 2025, indicating a robust growth trajectory in the polyimide sector [3].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][5][13] Core Views - The company reported a revenue of 5.44 billion yuan in Q1 2025, representing a year-on-year increase of 20.91% and a quarter-on-quarter decrease of 6.66%. The net profit attributable to the parent company was 1.16 billion yuan, up 116.18% year-on-year and 0.05% quarter-on-quarter, driven by the increase in both volume and price of nutritional products [5] - The company maintains its profit forecast, expecting net profits of 6.69 billion yuan, 7.51 billion yuan, and 8.08 billion yuan for 2025-2027, with corresponding EPS of 2.18, 2.44, and 2.63 yuan per share [5] - The company is optimistic about its "Chemicals+" and "Biological+" strategic main channels, and is steadily advancing project construction [5] Financial Summary - Revenue for 2023 was 15.12 billion yuan, with a year-on-year decrease of 5.1%. For 2024, revenue is projected to be 21.61 billion yuan, a year-on-year increase of 43.0%, and for 2025, it is expected to reach 25.86 billion yuan, a year-on-year increase of 19.6% [7][9] - The net profit attributable to the parent company for 2023 was 2.70 billion yuan, with a year-on-year decrease of 25.3%. For 2024, it is projected to be 5.87 billion yuan, a year-on-year increase of 117.0%, and for 2025, it is expected to be 6.69 billion yuan, a year-on-year increase of 14.0% [7][9] - The gross margin for 2023 was 33.0%, expected to rise to 41.8% in 2024 and remain stable in 2025 [10] Market Conditions - The market prices for Vitamin A (VA), Vitamin E (VE), and solid egg products have shown significant year-on-year changes, with VA increasing by 37.4% and VE by 109.9% in Q1 2025 [5] - The domestic export volume of methionine in Q1 2025 was 79,000 tons, a year-on-year increase of 7.35% [5] Project Progress - The company has achieved full production capacity of 300,000 tons of solid egg products and is nearing completion of the construction of 180,000 tons/year of liquid egg products [5] - New projects in aldehyde series, SA projects, and the first phase of the fragrance industrial park are progressing steadily [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][5][14] Core Views - The company achieved a revenue of 4.04 billion yuan in 2024, representing a year-on-year increase of 21.17%, and a net profit attributable to shareholders of 779 million yuan, up 178.40% year-on-year [5][6] - The first quarter of 2025 saw a revenue of 1.21 billion yuan, a 26.42% increase year-on-year, with a net profit of 401 million yuan, reflecting a 159.59% year-on-year growth [5][6] - The report anticipates continued growth in the refrigerant market, with profit forecasts for 2025-2027 being adjusted upwards, expecting net profits of 2.08 billion, 2.61 billion, and 2.97 billion yuan respectively [5][6] - The company plans to implement a mid-term dividend in 2025, with a cash dividend ratio of no more than 20% of the net profit attributable to shareholders for that period [7] Financial Performance Summary - In 2024, the company sold 125,400 tons of fluorinated refrigerants, generating a revenue of 3.27 billion yuan, with an average price of 26,056 yuan per ton [6] - The first quarter of 2025 showed a decline in sales volume for fluorinated refrigerants but a significant increase in average price, with a 43.5% rise compared to the average price in 2024 [6] - The company’s gross profit margin is projected to increase from 29.8% in 2024 to 48.9% in 2025, indicating improved profitability [9][11] Dividend and Employee Stock Plan - The company announced a cash dividend of 0.45 yuan per share for 2024, with a payout ratio of 35.07% [7] - An employee stock ownership plan was introduced, allowing for the purchase of up to 372,310 shares at a price of 20.47 yuan per share, aimed at enhancing employee confidence [7]

Investment Rating - The investment rating for the company is "Accumulate" [1] Core Views - The company confirmed a bottom reversal with its Q1 2025 performance being the best in nearly five years, achieving a revenue of 2.23 billion yuan, a year-on-year increase of 25.29%, and a net profit of 0.23 billion yuan, a year-on-year increase of 70.44% [2][6] Summary by Sections Financial Performance - In 2024, the company reported a revenue of 1.101 billion yuan, a decrease of 16.19% year-on-year, and a net profit of 0.14 billion yuan, down 31.59% year-on-year, with an EPS of 0.70 yuan [2][6] - The company sold 39.7 million detonators in 2024, a decrease of 21% year-on-year, while sales of explosives reached 54,000 tons, an increase of 2.97% year-on-year [3] Production Capacity and Market Demand - The company expanded its explosive production capacity through the acquisition of 98.70% of Hebei Tianning Chemical for 363 million yuan, increasing total explosive capacity to 114,000 tons [4] - The demand for detonators in overseas markets is strong, and the company has efficiently expanded its production capacity to meet this demand [4] Technological Advancements - The company developed a tunnel blasting intelligent loading robot, which is expected to open a market worth nearly 40 billion yuan in China, particularly suitable for tunnel construction in challenging environments [5] Profit Forecast - The updated profit forecast estimates revenues of 1.744 billion yuan, 2.454 billion yuan, and 2.886 billion yuan for 2025, 2026, and 2027 respectively, with corresponding net profits of 0.327 billion yuan, 0.463 billion yuan, and 0.510 billion yuan [6][10]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The report indicates that the refrigerant market is experiencing a sustained upward trend, with a gradual emergence of a main bullish market [5] - The company achieved a revenue of 5.8 billion yuan in Q1 2025, representing a year-on-year increase of 6.05%, and a net profit attributable to shareholders of 809 million yuan, up 160.64% year-on-year [5] - The report maintains profit forecasts for 2025-2027, expecting net profits of 5.128 billion, 7.285 billion, and 8.535 billion yuan respectively, with corresponding EPS of 1.90, 2.70, and 3.16 yuan [5] Financial Performance Summary - In Q1 2025, the company's revenue from various segments was as follows: fluorochemical raw materials (326 million yuan, +26.90%), refrigerants (2.618 billion yuan, +64.63%), and other segments [6] - The average price of refrigerants in Q1 2025 increased significantly, with a year-on-year rise of 58.08% to 37,504 yuan/ton [6] - The company’s total revenue for 2023 was 20.655 billion yuan, with a projected increase to 28.642 billion yuan in 2025, reflecting a year-on-year growth of 17.1% [8] Market Trends - The report highlights a continuous increase in air conditioning production in China, with expected growth rates of 9.9%, 14.1%, and 14.3% from May to July 2025 [7] - The demand for air conditioning in overseas markets is also strong, with significant sales increases reported by major manufacturers [7]

Core Viewpoint - A-shares showed mixed performance with the Shanghai Composite Index slightly declining while the Shenzhen Component and ChiNext Index experienced minor gains [1] Market Performance - As of the midday close, the Shanghai Composite Index was at 3287.45 points, down 0.03% - The Shenzhen Component was at 9863.90 points, up 0.09% - The ChiNext Index was at 1935.35 points, up 0.05% [1] Sector Performance - The beauty care, plastic products, and chemical products sectors led the gains, while the electricity, insurance, and liquor sectors faced the largest declines [2] Sector Rankings - The top performing sectors included: - Beauty Care: +3.22% with a total trading volume of 148.22 million hands and net inflow of 2.68 billion - Plastic Products: +3.15% with a total trading volume of 642.34 million hands and net inflow of 7.08 billion - Chemical Products: +2.48% with a total trading volume of 1466.20 million hands and net inflow of 8.32 billion - Automotive Parts: +2.44% with a total trading volume of 2088.77 million hands and net inflow of 18.83 billion - Engineering Machinery: +1.99% with a total trading volume of 276.91 million hands and net inflow of 0.89 billion [3] - The sectors with the largest declines included: - Electricity: -3.03% with a total trading volume of 4438.99 million hands and net outflow of 41.13 billion - Insurance: -2.08% with a total trading volume of 68.36 million hands and net outflow of 0.81 billion - Raw Materials: -1.43% with a total trading volume of 85.20 million hands and net outflow of 8.09 billion - Comprehensive: -1.23% with a total trading volume of 211.05 million hands and net inflow of 0.73 billion - Audio Equipment: -0.91% with a total trading volume of 237.04 million hands and net outflow of 2.84 billion [3]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The report indicates that the refrigerant market is experiencing a sustained upward trend, with a gradual emergence of a main bullish market [5] - The company achieved a revenue of 5.8 billion yuan in Q1 2025, representing a year-on-year increase of 6.05%, and a net profit attributable to shareholders of 809 million yuan, up 160.64% year-on-year [5] - The report maintains profit forecasts for 2025-2027, expecting net profits of 5.128 billion, 7.285 billion, and 8.535 billion yuan respectively, with corresponding EPS of 1.90, 2.70, and 3.16 yuan [5] Financial Performance - In Q1 2025, the company's revenue from various segments included 3.26 billion yuan from fluorochemical raw materials, 26.18 billion yuan from refrigerants, and 4.20 billion yuan from fluoropolymer materials, with refrigerant sales volume at 69,800 tons, up 4.14% year-on-year [6] - The average price of refrigerants in Q1 2025 was 37,504 yuan/ton, reflecting a year-on-year increase of 58.08% [6] - The company’s financial summary shows projected revenues increasing from 20.655 billion yuan in 2023 to 33.297 billion yuan in 2027, with net profits expected to rise from 944 million yuan to 8.535 billion yuan over the same period [8] Market Trends - The report highlights a significant increase in domestic air conditioning production, with expected growth rates of 9.9%, 14.1%, and 14.3% from May to July 2025 [7] - International demand for air conditioning is also strong, with notable sales increases reported by major manufacturers [7]

Core Viewpoint - The market showed mixed performance with the three major indices fluctuating, while PEEK material concept stocks continued to strengthen significantly [1] Market Overview - The market experienced narrow fluctuations in the morning session, with the three major indices showing mixed results. The total trading volume in the Shanghai and Shenzhen markets reached 645.7 billion, a decrease of 70.1 billion compared to the previous trading day [1] - Over 3,700 stocks in the market rose, indicating a general upward trend among individual stocks [1] Sector Performance - PEEK material concept stocks surged again, with Xinhan New Materials hitting the daily limit of a 20% increase [1] - Chemical stocks showed strong fluctuations, with multiple stocks such as Suqian Liansheng also reaching the daily limit [1] - Robotics concept stocks rebounded, with Fangzheng Electric Machine hitting the daily limit [1] - On the downside, electric power stocks collectively adjusted, with Leshan Electric Power hitting the daily limit down [1] Index Performance - By the end of the session, the Shanghai Composite Index fell by 0.03%, while the Shenzhen Component Index rose by 0.09%, and the ChiNext Index increased by 0.05% [1]

Core Insights - The company reported a slight increase in revenue for 2024, with total revenue, net profit attributable to shareholders, and net profit excluding non-recurring items reaching 2.554 billion, 787 million, and 745 million respectively, representing year-on-year growth of 2.62%, 9.79%, and 2.99% [1] - The company experienced a significant decline in Q4 2024 revenue and net profit compared to the previous quarter, with revenue down 27.4% year-on-year [1] - In Q1 2025, the company reported revenue, net profit attributable to shareholders, and net profit excluding non-recurring items of 577 million, 193 million, and 190 million respectively, with year-on-year changes of -8.58%, +14.18%, and +15.17% [1] Revenue Breakdown - The company's non-lithium basic warehouse business showed strong growth, with total revenue excluding the lithium extraction project from salt lakes reaching 2.455 billion, a year-on-year increase of 24.71% [2] - The salt lake lithium extraction project generated only 99 million in revenue, down 81% year-on-year, impacting overall revenue growth [2] - Revenue from various application areas in adsorption materials included: 256 million from metal resources (+30%), 568 million from life sciences (+28%), 688 million from water treatment and ultrapure water (+34%), 181 million from energy conservation and environmental protection (-2%), 56 million from food processing (+28%), and 200 million from chemicals and catalysis (+42%) [2] Profitability and Margins - The company achieved a gross margin of 49.47% in 2024, an increase of 0.8 percentage points year-on-year, benefiting from a higher proportion of mid-to-high-end adsorption materials and a decrease in the proportion of lower-margin system device revenue [2] - In Q1 2025, the gross margin improved to 50.79%, up 5.37 percentage points year-on-year, with continued strong growth in the life sciences, metal resources, and water treatment sectors [2] International Expansion - The company saw a significant increase in overseas revenue, which reached 655 million in 2024, a year-on-year growth of 45.1%, accounting for 25.65% of total revenue [3] - The company established a wholly-owned subsidiary in the United States and set up warehousing units in North America and Europe to facilitate localized business development [3] Future Projections - Revenue projections for 2025-2027 are estimated at 3.085 billion, 3.824 billion, and 4.679 billion respectively, with year-on-year growth rates of 20.78%, 23.98%, and 22.34% [3] - Net profit attributable to shareholders is expected to reach 959 million, 1.204 billion, and 1.548 billion for the same period, with growth rates of 21.85%, 25.55%, and 28.53% respectively [3] - The current stock price corresponds to a price-to-earnings ratio of 23.34, 18.59, and 14.47 for 2025-2027, reflecting the company's strong growth potential as a leading platform for adsorption materials [3]